396 related articles for article (PubMed ID: 28536639)
1. Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma.
Khan Z; Khan AA; Yadav H; Prasad GBKS; Bisen PS
Cell Mol Biol Lett; 2017; 22():8. PubMed ID: 28536639
[TBL] [Abstract][Full Text] [Related]
2. Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells.
Takaoka S; Iwase M; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S
Int J Oncol; 2007 Jun; 30(6):1469-76. PubMed ID: 17487368
[TBL] [Abstract][Full Text] [Related]
3. Survivin-Based Treatment Strategies for Squamous Cell Carcinoma.
Santarelli A; Mascitti M; Lo Russo L; Sartini D; Troiano G; Emanuelli M; Lo Muzio L
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587347
[TBL] [Abstract][Full Text] [Related]
4. Survivin multifaceted activity in head and neck carcinoma: current evidence and future therapeutic challenges.
Marioni G; D'Alessandro E; Bertolin A; Staffieri A
Acta Otolaryngol; 2010; 130(1):4-9. PubMed ID: 19322702
[TBL] [Abstract][Full Text] [Related]
5. Artepillin C as a targeting survivin molecule in oral squamous cell carcinoma cells in vitro: A preliminary study.
Pang S; Yee M; Saba Y; Chino T
J Oral Pathol Med; 2018 Jan; 47(1):48-52. PubMed ID: 28833597
[TBL] [Abstract][Full Text] [Related]
6. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
[TBL] [Abstract][Full Text] [Related]
7. Survivin Modulates Squamous Cell Carcinoma-Derived Stem-Like Cell Proliferation, Viability and Tumor Formation in Vivo.
Lotti R; Palazzo E; Petrachi T; Dallaglio K; Saltari A; Truzzi F; Quadri M; Puviani M; Maiorana A; Marconi A; Pincelli C
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26771605
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
9. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin.
Fetz V; Bier C; Habtemichael N; Schuon R; Schweitzer A; Kunkel M; Engels K; Kovács AF; Schneider S; Mann W; Stauber RH; Knauer SK
Int J Cancer; 2009 May; 124(9):2033-41. PubMed ID: 19130609
[TBL] [Abstract][Full Text] [Related]
10. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
Scheper MA; Nikitakis NG; Sauk JJ
Int J Oral Maxillofac Surg; 2007 Jul; 36(7):632-9. PubMed ID: 17566705
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of skin squamous cell carcinoma proliferation and promote apoptosis by dual silencing of NET-1 and survivin.
Ji ZJ; Wang JL; Chen L
Oncol Rep; 2015 Aug; 34(2):811-22. PubMed ID: 26080853
[TBL] [Abstract][Full Text] [Related]
12. Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B.
Qi G; Kudo Y; Ando T; Tsunematsu T; Shimizu N; Siriwardena SB; Yoshida M; Keikhaee MR; Ogawa I; Takata T
Oral Oncol; 2010 Apr; 46(4):263-70. PubMed ID: 20138567
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.
Phatak P; Byrnes KA; Mansour D; Liu L; Cao S; Li R; Rao JN; Turner DJ; Wang JY; Donahue JM
Oncogene; 2016 Apr; 35(16):2087-97. PubMed ID: 26234674
[TBL] [Abstract][Full Text] [Related]
14. Targeting survivin for therapeutic discovery: past, present, and future promises.
Peery RC; Liu JY; Zhang JT
Drug Discov Today; 2017 Oct; 22(10):1466-1477. PubMed ID: 28577912
[TBL] [Abstract][Full Text] [Related]
15. Cell growth inhibition and down-regulation of survivin by silibinin in a laryngeal squamous cell carcinoma cell line.
Bang CI; Paik SY; Sun DI; Joo YH; Kim MS
Ann Otol Rhinol Laryngol; 2008 Oct; 117(10):781-5. PubMed ID: 18998509
[TBL] [Abstract][Full Text] [Related]
16. Un-methylation of the survivin gene has no effect on immunohistochemical expression of survivin protein in lung cancer patients with squamous cell carcinoma.
Yalcin O; Budak M
Bratisl Lek Listy; 2017; 118(3):160-163. PubMed ID: 28319412
[TBL] [Abstract][Full Text] [Related]
17. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma.
Lo Muzio L; Staibano S; Pannone G; Mignogna MD; Mariggiò A; Salvatore G; Chieffi P; Tramontano D; De Rosa G; Altieri DC
Exp Mol Pathol; 2001 Jun; 70(3):249-54. PubMed ID: 11418003
[TBL] [Abstract][Full Text] [Related]
18. Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review).
Frassanito MA; Saltarella I; Vinella A; Muzio LL; Pannone G; Fumarulo R; Vacca A; Mariggiò MA
Oncol Rep; 2019 May; 41(5):2615-2624. PubMed ID: 30896830
[TBL] [Abstract][Full Text] [Related]
19. COX-independent antineoplastic effects of sulindac in oral cancer are mediated by survivin down-regulation.
Scheper MA; Sauk JJ; Nikitakis NG
Anticancer Res; 2006; 26(6B):4103-13. PubMed ID: 17201121
[TBL] [Abstract][Full Text] [Related]
20. Failure in downregulation of intratumoral survivin expression following neoadjuvant chemoradiation in esophageal cancer.
Vallböhmer D; Kuhn E; Warnecke-Eberz U; Brabender J; Hoffmann AC; Metzger R; Baldus SE; Drebber U; Hoelscher AH; Schneider PM
Pharmacogenomics; 2008 Jun; 9(6):681-90. PubMed ID: 18518847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
